Items where authors include "Kim, B.K."

Article

Lee, J.E. orcid.org/0000-0001-6173-2748, Nam, J.H., Kwon, S.H. orcid.org/0000-0002-1058-8392 et al. (2 more authors) (2024) Real‐world evidence of brigatinib as second‐line treatment after crizotinib for ALK+ non‐small cell lung cancer using South Korean claims data (K‐AREAL). Cancer Medicine, 13 (14). e70030. ISSN 2045-7634